Post-treatment PET scan is highly predictive of outcome (PFS and OS) in MCL pts treated with R-Hyper-CVAD in the frontline setting regardless of MIPI score

Autor:	Ewelina Protomastro, Gabriella Gadaleta, Tatyana Feldman, Mary Timberg, Tania Zielonka, Coleen Bejot, Jakub Svoboda, Anthony R. Mato, Andre Goy, Larysa Jessica Gromko, Andrew L. Pecora, Susan Stives, Pritish K. Bhattacharyya, Alexandria Campaiola, Harry Agress, Kar Fai Chow
Rok vydání:	2014
Předmět:	Oncology Cancer Research medicine.medical_specialty business.industry Hyper-CVAD Surgery Risk groups Internal medicine medicine Rituximab Post treatment business medicine.drug
Zdroj:	Journal of Clinical Oncology. 32:8557-8557
ISSN:	1527-7755 0732-183X
DOI:	10.1200/jco.2014.32.15_suppl.8557
Popis:	8557 Background: MIPI score (age, LDH, WBC, ECOG PS) defines 3 distinct risk groups in MCL pts. Though MIPI has been validated in series with dose intensive (DI) strategies and rituximab, a number ...
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::d359f9b19fb0ca23226cbaba9bc90ffa https://doi.org/10.1200/jco.2014.32.15_suppl.8557 Zobrazit plný text záznamu